Breakthrough in PTSD treatment: 68% remission in clinical trial
- The new PTSD treatment method has received FDA approval
- 68% of patients achieved remission
- Personalized approach using magnetic stimulation
Breakthrough in PTSD treatment
Recent research in the treatment of post-traumatic stress disorder (PTSD) is opening new horizons for patients who have not found relief through traditional methods. Wave Neuroscience, based in California, in collaboration with researchers from Texas A&M University, has developed an innovative technology that uses measurements of brain activity for targeted magnetic stimulation. This approach has received FDA approval and has already shown promising results in clinical trials.
According to data from Wave Neuroscience, patients participating in the clinical trial demonstrated a 52% reduction in PTSD symptoms, and 68% achieved remission. These results significantly exceed the outcomes of traditional treatment methods, such as psychotherapy and medications, which often do not provide sufficient relief. In the U.S., about 17.5 veterans commit suicide daily, and approximately 7% of veterans are diagnosed with PTSD each year.
PTSD can develop after traumatic events such as military actions, serious accidents, or violence. About 6% of Americans experience this disorder in their lifetime, with higher rates observed among women and veterans. Since PTSD was officially recognized in 1980, treatment has primarily focused on psychotherapy and selective serotonin reuptake inhibitors (SSRIs).
A new approach to treating PTSD
Wave Neuroscience reports significantly stronger preliminary results in its clinical trials compared to traditional methods. The company's Chief Medical Officer, Dr. Eric Vong, noted that their trials showed more than a fourfold increase in effectiveness compared to previous studies. "This is truly a qualitative leap in what we can offer patients," he said.
The approved technology is called magnetic e-resonance therapy (MeRT). It combines measurements of brain activity with targeted magnetic stimulation. First, an electroencephalogram (EEG) is conducted to record the brain's electrical signals. This data helps create a personalized treatment plan using transcranial magnetic stimulation (TMS).
During TMS, a coil placed on the scalp delivers magnetic pulses that stimulate brain activity. MeRT is unique in that it uses an AI-supported algorithm to tailor stimulation protocols based on the individual brain activity of the patient, allowing for a departure from the standard approach.
Personalized magnetic stimulation
Dr. Kenneth Ramos, a physician-scientist from Texas A&M University with extensive experience in precision medicine, helped guide the research. He emphasizes that most clinical interventions for treating PTSD are not effective, making it important to find new methods that can improve the quality of life for those suffering from this disorder.
Wave Neuroscience CEO Fred Walke noted that Ramos is ideally suited for the project due to his experience in personalized medicine. Unlike traditional TMS, which uses less individualized protocols, MeRT tailors treatment based on the specific brain activity of the patient.
Ramos also emphasized that even small biological differences between individuals can have significant implications for medical care. While people are 99.9% genetically similar, the remaining 0.1% can affect how each person responds to treatment. By considering these differences and customizing stimulation for each patient, researchers have observed a significant reduction in the severity of PTSD symptoms.
The future of PTSD treatment
The regulatory process reached an important milestone in 2024 when MeRT received breakthrough device designation from the FDA. Dr. Rick Silva, executive director of clinical trials at Texas A&M University, explained that this designation helps promising technologies move through regulatory review more quickly without compromising scientific or medical requirements.
Silva noted that progress in this area is particularly important as it can significantly improve access to new treatment methods for millions of people suffering from PTSD. This opens up new opportunities for patients who previously had no effective treatment options.
Despite the encouraging results, it is important to remember that the data comes from various studies and should not be taken as a direct comparison of treatment effectiveness. Nevertheless, new technologies like MeRT may represent an important step forward in the fight against PTSD and in improving the quality of life for millions of people.
Source: ScienceDaily
